Generic Name and Formulations:
Azithromycin 1%; oph. soln; contains benzalkonium chloride.
Indications for AZASITE:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not established. ≥1yr: 1 drop in affected eye(s) twice daily (8–12hrs apart) for 2 days then once daily for the next 5 days.
For topical ophthalmic use only. Discontinue if superinfection or hypersensitivity occurs. Remove contact lenses during therapy. Pregnancy (Cat.B). Nursing mothers.
Eye irritation; blurred vision, burning/pain, contact dermatitis, corneal erosion, dry eye, itching, ocular discharge.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age